Open Access

Synergistic immunotherapeutic effects of Lycium barbarum polysaccharide and interferon-α2b on the murine Renca renal cell carcinoma cell line in vitro and in vivo

  • Authors:
    • Shiyou Chen
    • Lunan Liang
    • Ying Wang
    • Jianhun Diao
    • Chunxiong Zhao
    • Gang Chen
    • Yunfeng He
    • Chunli Luo
    • Xiaohou Wu
    • Yao Zhang
  • View Affiliations

  • Published online on: August 20, 2015     https://doi.org/10.3892/mmr.2015.4230
  • Pages: 6727-6737
  • Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Novel therapeutic strategies to improve clinical efficacy in patients with renal cell carcinoma (RCC) are required. The possibility of combination therapy with Lycium barbarum polysaccharides (LBP) and recombinant interferon (IFN)‑α2b remains to be elucidated in RCC. The present study investigated the putative synergistic immunotherapeutic roles of LBP and IFN‑α2b against RCC in vitro and in vivo. The mouse RCC cell line, Renca, was used for in vitro experiments. Treatment of the cells with a combination of LBP and IFN‑α2b markedly inhibited cell proliferation, retarded cell cycle growth and promoted apoptosis in the Renca cells. Western blot analysis revealed that LBP and IFN‑α2b synergistically downregulated the expression levels of cyclin D1, c‑Myc and Bcl‑2, and upregulated the expression of the antiapoptotic protein, Bax. Myeloid‑derived suppressor cells (MDSCs) were markedly upregulated during tumour progression and promoted tumour growth by inhibiting the T‑cell‑mediated immune response. In vivo, a marked reduction in the MDSC ratio and tumour volume was observed in a group receiving combined treatment with LBP and IFN‑α2b in a xenograft tumour model. In conclusion, the present study suggested that the combination of LBP and IFN‑α2b is likely to be more effective in treating murine RCC compared with the less pronounced immunotherapeutic effects of administering LBP or IFN-α2b alone.
View Figures
View References

Related Articles

Journal Cover

November-2015
Volume 12 Issue 5

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen S, Liang L, Wang Y, Diao J, Zhao C, Chen G, He Y, Luo C, Wu X, Zhang Y, Zhang Y, et al: Synergistic immunotherapeutic effects of Lycium barbarum polysaccharide and interferon-α2b on the murine Renca renal cell carcinoma cell line in vitro and in vivo. Mol Med Rep 12: 6727-6737, 2015
APA
Chen, S., Liang, L., Wang, Y., Diao, J., Zhao, C., Chen, G. ... Zhang, Y. (2015). Synergistic immunotherapeutic effects of Lycium barbarum polysaccharide and interferon-α2b on the murine Renca renal cell carcinoma cell line in vitro and in vivo. Molecular Medicine Reports, 12, 6727-6737. https://doi.org/10.3892/mmr.2015.4230
MLA
Chen, S., Liang, L., Wang, Y., Diao, J., Zhao, C., Chen, G., He, Y., Luo, C., Wu, X., Zhang, Y."Synergistic immunotherapeutic effects of Lycium barbarum polysaccharide and interferon-α2b on the murine Renca renal cell carcinoma cell line in vitro and in vivo". Molecular Medicine Reports 12.5 (2015): 6727-6737.
Chicago
Chen, S., Liang, L., Wang, Y., Diao, J., Zhao, C., Chen, G., He, Y., Luo, C., Wu, X., Zhang, Y."Synergistic immunotherapeutic effects of Lycium barbarum polysaccharide and interferon-α2b on the murine Renca renal cell carcinoma cell line in vitro and in vivo". Molecular Medicine Reports 12, no. 5 (2015): 6727-6737. https://doi.org/10.3892/mmr.2015.4230